New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - clonidine 2.5mg - transdermal patch - 2.5 mg - active: clonidine 2.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - clonidine 5mg - transdermal patch - 5 mg - active: clonidine 5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - clonidine 7.5mg - transdermal patch - 7.5 mg - active: clonidine 7.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - ciclosporin 0.9 mg/ml - eye drops, solution - 900 mcg/ml - active: ciclosporin 0.9 mg/ml excipient: dibasic sodium phosphate hydrochloric acid monobasic sodium phosphate dihydrate octoxinol 40 polyethylene glycol hydrogenated castor oil povidone sodium chloride sodium hydroxide water for injection - cequa is indicated to increase tear production in patients with moderate to severe keratoconjunctivits sicca (dry eye), where prior use of artificial tears has not been sufficient.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - remestemcel-l (100 million human mesenchymal stem cells in 15ml) - solution for infusion - 100 million cells in 15ml - active: remestemcel-l (100 million human mesenchymal stem cells in 15ml) excipient: albumin dimethyl sulfoxide plasma-lyte a - prochymal is indicated for the rescue of patients nlt 6 months to 17 years of age with acute graft versus host disease (agvhd), refractory to treatment with systemic corticosteroid therapy or other immunosuppressive agents. prochymal use under these conditions is limited to grades b to d of the disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - macrogols 59 g;  ; potassium chloride 0.7425 g; sodium bicarbonate 1.685 g;  ; sodium chloride 1.465 g; sodium sulfate 5.685 g;   - powder for oral solution - active: macrogols 59 g   potassium chloride 0.7425 g sodium bicarbonate 1.685 g   sodium chloride 1.465 g sodium sulfate 5.685 g   excipient: aspartame vanilla

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - macrogol 3350 13.125 g;  ; potassium chloride 46.6mg; sodium bicarbonate 178.5mg; sodium chloride 350.7mg - powder for oral solution - 13.8 g - active: macrogol 3350 13.125 g   potassium chloride 46.6mg sodium bicarbonate 178.5mg sodium chloride 350.7mg excipient: acesulfame lemon & lime. trusil 463842 - for effective relief from constipation, treatment of chronic constipation. movicol is also effective in resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by physical examination of abdomen and rectum.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - macrogol 3350 6.536 g;  ; potassium chloride 23.3mg; sodium bicarbonate 89.3mg; sodium chloride 175.4mg - powder for oral solution - active: macrogol 3350 6.536 g   potassium chloride 23.3mg sodium bicarbonate 89.3mg sodium chloride 175.4mg excipient: acesulfame potassium lemon & lime. trusil 463842 - for effective relief from constipation, treatment of chronic constipation. movicol is also effective in resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by physical examination of abdomen and rectum.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - macrogol 3350 100 g;  ; potassium chloride 1.015 g; sodium chloride 2.691 g; sodium sulfate 7.5 g;  ; ascorbic acid 4.7 g;  ; sodium ascorbate 5.9 g;   - powder for oral solution - active: macrogol 3350 100 g   potassium chloride 1.015 g sodium chloride 2.691 g sodium sulfate 7.5 g   excipient: acesulfame potassium aspartame lemon flavour v3938-1n1 active: ascorbic acid 4.7 g   sodium ascorbate 5.9 g   - moviprep is used for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g., bowel endoscopy, lower gastrointestinal radiology or digestive tract surgery.

New Zealand - English - Medsafe (Medicines Safety Authority)

carsl consulting - sterculia 62%{relative} - oral granules - 62% w/w - active: sterculia 62%{relative} excipient: hard paraffin purified talc sodium bicarbonate sucrose titanium dioxide vanillin